Nimbus Therapeutics - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeNimbus Therapeutics
Nimbus Therapeutics logo

Nimbus Therapeutics

0 followers

About Nimbus Therapeutics

Nimbus Therapeutics is a biotechnology company focused on discovering and developing clinically meaningful small molecule medicines with high target specificity. Based in Boston, Massachusetts, the company emphasizes design with intentionality across people, targets, and molecules to advance oncology, immunology, and metabolic indications. Nimbus highlights world-class expertise and leading-edge technologies to drive translational medicine and clinical development, aiming to improve patients’ lives. The organization has a track record of success in developing targeted, selective therapies.

Recent News

Recent Deals

No recent deals for this company.

Key Team Members

Abbas Kazimi

Chief Executive Officer

Scott Edmondson

Senior Vice President, Head of Chemistry

Ian Sanderson

Chief Financial Officer

Key Facts

HQ Location

Boston, United States

Founded

2009

Employees

51 - 200

Status

Private

Website

https://nimbustx.com